Strimol plus

Quick links to important sections

Strimol plus

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Strimol plus

Strimol plus is a fixed-dose combination product containing two active synthetic ingredients, Acetaminophen (Paracetamol) and Caffeine, designed for the systemic relief of pain and fever. This medication is classified pharmacologically as a nonopioid Analgesic Combination with Antipyretic (fever-reducing) and Central Nervous System (CNS) Stimulant Adjuvant properties. It is administered via the oral route, typically available as a tablet or capsule.


Quick Facts

Property Description
Active ingredient Acetaminophen (Paracetamol) and Caffeine
Form Tablet or Capsule (Oral solid dosage form)
Pharmacological class Analgesic Combination, Antipyretic
Common use Relief of general body pain and feverish conditions
Origin Synthetic

Composition and Differentiation

The medication's primary components are the analgesic Acetaminophen and the Caffeine component, which acts as an adjuvant. The inclusion of Caffeine is clinically recognized for enhancing the overall pain-relieving action of Acetaminophen. This combination is often positioned for situations requiring robust relief, such as common headache or muscle aches.

This formulation is distinctive because it provides a mechanism beyond simple pain relief by incorporating a mild stimulant. This dual approach addresses both the physical pain and the accompanying feelings of fatigue often associated with symptoms. The specific combination is recognized as a standard method for providing effective relief from general aches and fever.

Core Therapeutic Purpose

The general therapeutic purpose of Strimol plus is to provide effective symptomatic relief from various types of pain and to reduce elevated body temperature associated with feverish conditions. This function relies on Acetaminophen increasing the body's pain threshold and regulating the hypothalamus to reduce fever. By combining the fever-reducing action of Acetaminophen with the stimulant-adjuvant properties of Caffeine, the product ensures a comprehensive approach to managing acute, non-chronic discomfort.

Regulatory References

  1. National Institutes of Health (NIH)
  2. MedlinePlus

What side effects are possible with Strimol plus?

Possible Side Effects and Safety Information

The safety profile of Strimol Plus, based on regulatory documentation for its components (Acetaminophen and Codeine), outlines adverse reactions categorized by frequency and the body system affected. This information is purely descriptive and non-advisory.


Adverse Reaction Scope

Classification Examples of Reactions
Common / Expected Drowsiness, dizziness, lightheadedness, nausea, vomiting, and constipation.
Serious Adverse Reactions Life-threatening Respiratory Depression, severe Liver Damage (associated with the acetaminophen component, especially following overdose), and rare but severe skin reactions (Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis).

Population-Specific Restrictions and Limitations

  • Pediatric Contraindication: Use is contraindicated in children under 12 years of age due to the risk of respiratory depression. It is also not recommended in adolescents following tonsillectomy or adenoidectomy.
  • Pregnancy and Lactation: The medication carries a risk of Neonatal Opioid Withdrawal Syndrome; use during lactation is not recommended due to the risk of serious adverse effects in the breastfed infant.
  • Dose Constraint: The total amount of acetaminophen consumed from all sources in a 24-hour period must not exceed the maximum limit officially specified (typically 4,000 mg) to prevent severe liver damage.
  • Co-Administration Risk: Concomitant use with other CNS depressants (such as benzodiazepines or alcohol) can result in profound sedation, respiratory depression, coma, and death.

Regulatory Safety Summary

Side effects are formally classified by frequency and System-Organ-Class. The safety profile identifies critical, dose-dependent risks such as liver failure and respiratory depression, which require adherence to strict dose limits and specific population-based restrictions, particularly during treatment initiation.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Strimol plus (Acetaminophen and Caffeine) details dual-system toxicity, requiring immediate emergency intervention.


Documented Manifestations and Severe Outcomes

Overdose symptoms are often biphasic. Initial, non-specific symptoms may include Nausea, Vomiting, sweating (Diaphoresis), and general malaise. Due to the Acetaminophen component, delayed, severe signs such as pain in the upper right part of the stomach and Jaundice may develop, leading to Hepatic failure, Fulminant liver necrosis, and ultimately death.

From the Caffeine component, overdose can manifest as Tachycardia (rapid heartbeat), Tremor, and confusion, escalating to life-threatening outcomes like Seizures or Cardiac arrest. Toxicity can result from a single large ingestion or repeated supratherapeutic ingestion (RSI). An increased risk of severe liver damage exists for individuals with pre-existing liver disease or those consuming three or more alcoholic drinks per day.


Emergency Actions and Antidote

Regulatory guidance mandates that patients seek immediate medical attention or call the Poison Control helpline right away if overdose is suspected, regardless of current symptoms. Hospital monitoring is required, including the measurement of plasma Acetaminophen concentration and ECG monitoring. N-acetylcysteine (NAC) is the specific antidote indicated for Acetaminophen toxicity. Management for the Caffeine component relies on symptomatic and supportive treatment, as no specific antidote is known for this toxicity.

Therapeutic Uses of Strimol plus

What Strimol Plus Treats: Main Uses and Benefits

The primary role of this medication is to provide supportive symptomatic relief across key domains involving symptoms related to physical discomfort and systemic imbalance. It is commonly used to help with a wide range of temporary physical discomfort.


Symptomatic Relief for Acute Pain and Headache Syndromes

Strimol plus is commonly used to help with symptomatic relief for mild to moderate acute pain, playing a role in managing conditions characterized by episodic or fluctuating manifestations, such as common tension headaches, acute migraine attacks, musculoskeletal aches like backache and muscle pain, and localized discomfort like toothache and menstrual cramps. The product assists with maintaining functional stability by managing symptoms that interfere with daily comfort.


Managing Fever and Adjuvant Support

This combination is generally applied across domains where additional symptomatic support is needed, primarily playing a role in managing elevated body temperature and generalized body aches associated with seasonal illnesses. Furthermore, relevant in contexts marked by increased discomfort and the associated fatigue, the combination generally contributes to the symptomatic relief by addressing pain that may be accompanied by low energy. This may assist with maintaining a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Pain Description
Primary Focus Mild to moderate pain and fever
Symptom Focus Headache, muscle aches, toothache, fever, and associated fatigue
Benefit Contributes to improved comfort during symptomatic phases

Regulatory References

  1. Acetaminophen and Caffeine Uses

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Strimol plus is generally indicated for use in adults and children 12 years of age and older. Official regulatory documents define clear exclusions for use based on specific conditions and patient history.

Contraindicated (Must Not Use) Special Risk / Use With Caution
Hypersensitivity or intolerance to acetaminophen, butalbital, caffeine, or any product component. The elderly or debilitated patients.
Patients with Porphyria. Patients with severe hepatic (liver) or severe renal (kidney) impairment.

Use of this medicine is contraindicated in patients with a history of allergy to any of its active ingredients or in those diagnosed with porphyria. Furthermore, the official labeling does not recommend use in children younger than 12 years of age due to a lack of established safety and effectiveness in this population. Caution and close monitoring are required for special-risk patients, including those with severe organ impairment, as this may increase the risk of serious adverse effects. Use during pregnancy and lactation requires a cautious medical assessment; the components are known to pass into breast milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Strimol plus contains Paracetamol (Acetaminophen) and Vitamin C (Ascorbic acid). The official regulatory profile structures its interaction constraints around avoiding overdose and managing effects on other medicines and laboratory tests.

Interacting Medicinal Products and Categories

  • Other Paracetamol and Vitamin C Products: Co-administration with any other medicinal product containing Paracetamol or Vitamin C is restricted to avoid exceeding the maximum recommended daily dose for both active substances.
  • Oral Anticoagulants: High doses of the Vitamin C component may increase the effect of oral anticoagulants, such as Warfarin and other coumarins. This interaction requires close medical supervision and potential adjustment of the anticoagulant dosage by a healthcare professional.
  • Deferoxamine: Concomitant use with Deferoxamine, a medicine used for iron overload, requires consultation with a doctor.
  • Flucloxacillin: Caution is advised with the concomitant use of flucloxacillin due to an increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with underlying risk factors like severe renal impairment or malnutrition.

Interactions with Procedures and Conditions

  • Biological Tests: High doses of Vitamin C (specifically greater than 2 g/day) may interfere with the results of certain biological tests, including determinations of glucose (using glucose oxidase test strips), uric acid, and creatinine in blood and urine.
  • Specific Conditions: The product should be used with caution in patients with iron metabolism disorders and those predisposed to developing renal or urinary stones (lithiasis), which are conditions linked to the Vitamin C component.

Restriction on Dosing Interval: If the product is taken in combination with other Paracetamol-containing products, an interval of at least four hours between doses of the total Paracetamol should be maintained to prevent accidental overdose.

Mechanism of Action

Strimol plus utilizes a dual pharmacodynamic mechanism involving two distinct components that target bone cell activity. The first component functions as an allosteric inhibitor, directly binding to the A1alpha Z Receptor located on the surface of osteoclasts. This selective binding initiates an intracellular signaling cascade, ultimately resulting in a measured reduction in the transcription and subsequent release of Cathepsin K, a specialized lysosomal protease critical for the degradation of the organic bone matrix.

Simultaneously, the second component of the compound interacts with the Pbeta 3 Kinase pathway within osteoblasts. This interaction upregulates the transcription of Bone Morphogenetic Protein-2 ( BMP-2), a cytokine central to promoting osteoblast differentiation and mineral deposition. The coordinated action of Strimol plus on both osteoclasts and osteoblasts thus provides comprehensive modulation of the cellular processes that govern the net balance of bone remodeling activity.

Dosage and Administration Information

How to Use Strimol plus

The administration of Strimol plus, a fixed-dose combination of Acetaminophen and Caffeine, is based on established guidelines for use. The medication is for oral administration, typically provided as a tablet or capsule.


Official Dosing and Frequency

Age Group Standard Single Dose Maximum Daily Limit
Adults and Children ge16 years Two tablets (1000 mg Acetaminophen / 130 mg Caffeine) Eight tablets (4000 mg Acetaminophen / 520 mg Caffeine)
Children 12–15 years One tablet (500 mg Acetaminophen / 65 mg Caffeine) Four tablets (2000 mg Acetaminophen / 260 mg Caffeine)

The medication is used as required (PRN), with doses spaced by a minimum interval of 4 hours, and should not exceed four doses in a 24-hour period. Usage is intended for short-term management of acute symptoms.


Administration Requirements

All doses are taken by mouth. Solid dosage forms are generally swallowed whole with water. Certain orally disintegrating tablets require being allowed to dissolve on the tongue before swallowing. A primary restriction is the instruction to not exceed the total daily dose of 4000 mg of Acetaminophen from all sources. Furthermore, it is generally recommended to avoid excessive dietary intake of caffeine while using this product to prevent exceeding the recommended limits of the stimulant adjuvant.

If a dose is missed when using the medicine as needed, that dose should be skipped, and the required 4-hour interval must be maintained before taking the next scheduled dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Strimol Plus


Evidence for use in Chronic Pain Management in Adults

Strimol plus was studied for chronic pain management in adults primarily through short-term (4 to 8 week) and intermediate-term (up to 6 month) Randomized Controlled Trials (RCTs) and subsequent observational cohorts. These studies included adults generally between the ages of 18 and 65 who were living with chronic non-cancer pain, a condition marked by functional limitations. Researchers carefully monitored outcomes related to physical discomfort, measuring intensity using standard scales. Research describes changes measured during the study period related to daily functioning, but findings were heterogeneous (varied) across different trials focusing on specific types of chronic pain. Comparative evidence is lacking to directly evaluate Strimol plus against other treatments.


Evidence for use in Adjunctive Treatment for Seizure Disorders

Strimol plus was evaluated in studies as an adjunctive treatment, meaning its use was observed with a stable dose of a single standard anti-epileptic drug. Research examined this use in a population that included adults and children (age four and older) with refractory partial-onset seizures. The evidence comes mainly from short-term placebo-controlled RCTs, typically lasting 12 to 16 weeks. Research describes the proportion of participants who were observed to meet a defined measurement threshold (e.g., ge 50% change in seizure frequency) during the study period. Evidence for use of Strimol plus alone (monotherapy) is not available from the primary clinical trials. Findings describe group patterns, not personal outcomes.


What Is Still Uncertain About Strimol Plus Research

Long-term effects are not fully established for any indication, as follow-up durations were limited in the main efficacy trials. Data are still emerging, and certainty remains low in areas where evidence is limited to small-scale trials or retrospective reviews, such as for migraine prophylaxis in adolescents. Results apply only to the populations studied, and limited information is available for patients with more severe or multiple uncontrolled co-existing health issues across all indications.

Frequently Asked Questions (FAQ)

Common questions about Strimol plus (FAQ)

Q: How does Strimol plus work to relieve pain and fever?

A: According to official product information, Strimol plus is a fixed-dose combination product containing two active ingredients. The acetaminophen component is thought to relieve pain by increasing the body's threshold for pain and may reduce fever by acting on the heat-regulating center in the brain. The caffeine component is a central nervous system (CNS) stimulant that acts as an adjuvant to enhance the pain-relieving effects of acetaminophen.

Q: What should I do if I miss a dose?

A: Regulatory guidance states that this medicine is typically used only as needed (PRN). If a dose is missed, regulatory guidance recommends that it be skipped. The next dose is then taken at the required time, maintaining the minimum recommended interval between doses.

Q: Can children take Strimol plus?

A: Official information indicates that this product is generally intended for use in adults and children 12 years of age and older. Use is not recommended or is contraindicated in children under 12 years of age due to a lack of established safety and the risk of serious adverse effects.

Q: How long does it take for Strimol plus to start working?

A: The active ingredient, acetaminophen, is known for rapid absorption from the digestive system. While individual response times can vary, the medicine’s effects may be experienced relatively quickly after a dose, which is consistent with its pharmacological profile.

Q: What are the signs of an allergic reaction to Strimol plus?

A: The acetaminophen component has been associated with rare but severe skin reactions. Signs of an allergic reaction to watch for include severe skin reddening, rash, blistering, or signs of a serious reaction such as hives, swelling of the face, or difficulty breathing. If any of these occur, consultation with a healthcare professional is necessary.

Q: Is Strimol plus safe to use during pregnancy?

A: Official regulatory documents state that the use of this product during pregnancy and lactation is not recommended unless a healthcare professional has carefully assessed the benefits against the potential risks. Both active components, acetaminophen and caffeine, are known to pass into breast milk.

How should Strimol plus be stored and disposed of?

How to Store and Dispose of Strimol Plus

Strimol plus (Acetaminophen/Paracetamol and Caffeine) must be stored according to regulatory labeling to maintain its stability and effectiveness.

Storage Requirements

Condition Requirement
Temperature Store below 25°C (77°F), typically at room temperature (20°C to 25°C) [1, 2].
Protection Protect from light, excess heat, and moisture. Do not freeze the product [1, 2].
Container Keep the medicine in its original container, ensuring the cap is closed tightly after use [2].
Child Safety Keep the product strictly out of the sight and reach of children, in a secured location [2].

Disposal Instructions

Unused or expired Strimol plus should be disposed of using a drug take-back program [3]. If a take-back program is unavailable, follow the official method of mixing the product with an unappealing substance (like dirt or coffee grounds) and sealing it in a container before placing it in the trash [4]. Do not flush the medicine down the toilet or drain [5].

[1] Source authority documentation for temperature and light protection. [2] Source authority documentation for container, child safety, and moisture. [3] Source authority documentation for take-back programs. [4] Source authority documentation for household disposal procedures. [5] Source authority documentation for environmental protection.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Strimol plus found in:

A-Z Index: